- Home
- CLDX vs CET Comparison
CLDX vs CET Comparison
Compare CLDX & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- CET
- Stock Information
- Founded
- CLDX N/A
- CET 1929
- Country
- CLDX United States
- CET United States
- Employees
- CLDX N/A
- CET N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CET Finance/Investors Services
- Sector
- CLDX Health Care
- CET Finance
- Exchange
- CLDX Nasdaq
- CET Nasdaq
- Market Cap
- CLDX 1.3B
- CET 1.3B
- IPO Year
- CLDX 2008
- CET N/A
- Fundamental
- Price
- CLDX $16.85
- CET $45.12
- Analyst Decision
- CLDX Buy
- CET
- Analyst Count
- CLDX 8
- CET 0
- Target Price
- CLDX $54.29
- CET N/A
- AVG Volume (30 Days)
- CLDX 767.1K
- CET 25.6K
- Earning Date
- CLDX 05-05-2025
- CET 01-01-0001
- Dividend Yield
- CLDX N/A
- CET 5.00%
- EPS Growth
- CLDX N/A
- CET 26.33
- EPS
- CLDX N/A
- CET 9.95
- Revenue
- CLDX $7,020,000.00
- CET $23,698,535.00
- Revenue This Year
- CLDX N/A
- CET N/A
- Revenue Next Year
- CLDX $27.01
- CET N/A
- P/E Ratio
- CLDX N/A
- CET $4.52
- Revenue Growth
- CLDX 1.99
- CET 11.75
- 52 Week Low
- CLDX $16.75
- CET $40.08
- 52 Week High
- CLDX $47.00
- CET $49.51
- Technical
- Relative Strength Index (RSI)
- CLDX 29.79
- CET 42.24
- Support Level
- CLDX $19.48
- CET $44.63
- Resistance Level
- CLDX $20.38
- CET $45.89
- Average True Range (ATR)
- CLDX 1.03
- CET 0.63
- MACD
- CLDX -0.17
- CET 0.05
- Stochastic Oscillator
- CLDX 2.19
- CET 42.28
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.